Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MIDODRINE HYDROCHLORIDE USP, with a corresponding US DMF Number 30990.
Remarkably, this DMF maintains an Active status since its submission on November 07, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 13, 2017, and payment made on December 08, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II